AVALYN PHARMA

avalyn-pharma-logo

Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.

#SimilarOrganizations #People #Financial #Event #Website #More

AVALYN PHARMA

Social Links:

Industry:
Biopharma Biotechnology Medical Pharmaceutical

Founded:
2011-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.avalynpharma.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
272.5 M USD

Technology used in webpage:
Font Awesome CrUX Dataset CrUX Top 10m Ninja Forms


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

arrakis-therapeutics-logo

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

epivario-logo

EpiVario

EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

halo-labs-logo

Halo Labs

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.


Current Advisors List

jill-carroll_image

Jill Carroll Board Member @ Avalyn Pharma
Board_member

gianna-hoffman-luca_image

Gianna Hoffman-Luca Board Member @ Avalyn Pharma
Board_member

Current Employees Featured

not_available_image

Mark W. Surber
Mark W. Surber Founder and CSO @ Avalyn Pharma
Founder and CSO
2017-03-01

lyn-baranowski_image

Lyn Baranowski
Lyn Baranowski CEO @ Avalyn Pharma
CEO

melissa-rhodes_image

Melissa Rhodes
Melissa Rhodes Chief Operating Officer @ Avalyn Pharma
Chief Operating Officer
2023-09-01

bruce-montgomery_image

Bruce Montgomery
Bruce Montgomery CEO @ Avalyn Pharma
CEO
2017-03-01

douglas-carlson_image

Douglas Carlson
Douglas Carlson Chief Financial Officer and Chief Business Officer @ Avalyn Pharma
Chief Financial Officer and Chief Business Officer
2024-05-01

Founder


not_available_image

Mark W. Surber

Investors List

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Avalyn Pharma

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series C - Avalyn Pharma

sr-one_image

SR One

SR One investment in Series C - Avalyn Pharma

norwest-venture-partners_image

Norwest Venture Partners

Norwest Venture Partners investment in Series C - Avalyn Pharma

rivervest_image

RiverVest

RiverVest investment in Series C - Avalyn Pharma

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series C - Avalyn Pharma

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series C - Avalyn Pharma

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series C - Avalyn Pharma

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series C - Avalyn Pharma

vida-ventures_image

Vida Ventures

Vida Ventures investment in Series C - Avalyn Pharma

Official Site Inspections

http://www.avalynpharma.com Semrush global rank: 3.04 M Semrush visits lastest month: 5.26 K

  • Host name: 170.251.121.34.bc.googleusercontent.com
  • IP address: 34.121.251.170
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Avalyn Pharma"

About | Avalyn Pharma Inc

While existing therapeutic options slow disease progression, their significant side effects often limit patientโ€™s persistence and compliance with the drugs. We are dedicated to making a โ€ฆSee details»

Avalyn Pharma - LinkedIn

Avalyn Pharma | 6,852 followers on LinkedIn. Revolutionizing respiratory care with every breath | Avalyn is reimagining the future of pulmonary fibrosis treatment, with a pipeline of new inhaled ...See details»

Avalyn Pharma 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Avalyn Pharma. Use the PitchBook Platform to explore the full profile.See details»

Avalyn Pharma - Crunchbase Company Profile & Funding

Avalyn Pharma is a biopharma company developing therapies for the โ€ฆSee details»

Avalyn Pharma - 2025 Company Profile & Team - Tracxn

Avalyn Pharma - Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis. Raised a total funding of $389M over 6 rounds from 23 investors.See details»

Avalyn Pharma - Craft

Avalyn Pharma is a company that develops therapies for the treatment of severe respiratory diseases. It provides AP01, a pirfenidone solution for inhalation designed to treat idiopathic โ€ฆSee details»

Avalyn Pharma Inc. Company Overview, Contact Details

Apr 27, 2020 Learn more about Avalyn Pharma Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

Avalyn Pharma Inc | Targeted therapies for rare lung โ€ฆ

Avalyn is a clinical-stage biotech company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial โ€ฆSee details»

Avalyn Strengthens Leadership Team with Key Appointments,

Nov 6, 2023 Jim Bishop joined Avalyn in October 2023 as senior vice president, business operations, and he is responsible for corporate strategy and overseeing multiple functions โ€ฆSee details»

Avalyn Pharma Inc. Company Profile | Seattle, WA | Competitors ...

Find company research, competitor information, contact details & financial data for Avalyn Pharma Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»

Avalyn Pharma Inc. Management Team | Org Chart - RocketReach

Avalyn Pharma Inc. employs 49 employees. The Avalyn Pharma Inc. management team includes Lyn Baranowski (Chief Executive Officer), Alyssa Black (Human Resources Director), and โ€ฆSee details»

Avalyn Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Aug 17, 2025 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase โ€ฆSee details»

Culture & Careers - Avalyn Pharma Inc

Diversity, inclusion, and equity are vital elements of our culture, and we work hard to ensure all voices are welcomed, heard, and respected. Our goal is to continue building a diverse ad โ€ฆSee details»

Avalyn Pharma Careers | Levels.fyi

Avalyn Pharma is a clinical-stage biopharmaceutical company focused on developing inhaled therapies for rare respiratory diseases. Their lead candidate, AP01, is in Phase 2b trials for โ€ฆSee details»

Avalyn Pharma Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Avalyn Pharma Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»

Contact - Avalyn Pharma Inc

AVALYN Pharma 245 First Street, 18th Floor Cambridge, MA 02142See details»

Avalyn Pharma - LifeScienceHistory.com

Avalyn, formerly Genoa Pharmaceuticals, is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe โ€ฆSee details»

Our Approach | Avalyn Pharma Inc

Our therapeutic focus Avalyn is focused on enhancing the lives of patients by developing innovative inhaled therapies that address unmet needs in the treatment of rare respiratory โ€ฆSee details»

Press Releases | Avalyn Pharma Inc

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025See details»

Patients & Caregivers - Avalyn Pharma Inc

Our Commitment to Patients and Caregivers At Avalyn, patients are at the center of our business, and we strive to meet the needs of the patient community we serve in every aspect of our โ€ฆSee details»

linkstock.net © 2022. All rights reserved